A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-08
DOI
10.1038/srep36631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of Map Kinases Inhibits Microglial Activation and Attenuates Neuronal Cell Death Induced by α-Synuclein Protofibrils
- (2017) H. Wilms et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Molecular Mechanisms of Amyloid Oligomers Toxicity
- (2016) Rakez Kayed et al. JOURNAL OF ALZHEIMERS DISEASE
- Interactions between misfolded protein oligomers and membranes: A central topic in neurodegenerative diseases?
- (2015) Maria Andreasen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Precision medicine: Clarity for the clinical and biological complexity of Alzheimer’s and Parkinson’s diseases
- (2015) Thomas J. Montine et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease
- (2015) J.G. Doria et al. NEUROBIOLOGY OF DISEASE
- Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation
- (2014) Peng-xin Xu et al. BEHAVIOURAL BRAIN RESEARCH
- Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
- (2014) Marcos J. Guerrero-Muñoz et al. BIOCHEMICAL PHARMACOLOGY
- Pan-Amyloid Oligomer Specific scFv Antibody Attenuates Memory Deficits and Brain Amyloid Burden in Mice with Alzheimer’s Disease
- (2014) Min Zhao et al. Current Alzheimer Research
- Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease
- (2014) Wei-wei Zhou et al. FREE RADICAL BIOLOGY AND MEDICINE
- Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson’s disease and other Lewy body disorders
- (2014) Veronica Lindström et al. Immunotherapy
- Impaired Brain Energy Metabolism in the BACHD Mouse Model of Huntington's Disease: Critical Role of Astrocyte–Neuron Interactions
- (2014) Lydie Boussicault et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
- (2014) Nan Wang et al. NATURE MEDICINE
- Zonisamide Attenuates α-Synuclein Neurotoxicity by an Aggregation-Independent Mechanism in a Rat Model of Familial Parkinson’s Disease
- (2014) Shigeki Arawaka et al. PLoS One
- Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
- (2013) Gabor G. Kovacs et al. ACTA NEUROPATHOLOGICA
- Amylin deposition in the brain: A second amyloid in Alzheimer disease?
- (2013) Kaleena Jackson et al. ANNALS OF NEUROLOGY
- A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease
- (2013) Han-Yun Hsiao et al. HUMAN MOLECULAR GENETICS
- Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice
- (2013) Suhail Rasool et al. JOURNAL OF NEUROCHEMISTRY
- A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease
- (2013) D. A. Simmons et al. JOURNAL OF NEUROSCIENCE
- Age-Related Behavioral Phenotype of an Astrocytic Monoamine Oxidase-B Transgenic Mouse Model of Parkinson’s Disease
- (2013) Christopher A. Lieu et al. PLoS One
- Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
- (2012) Cristian A. Lasagna-Reeves et al. FASEB JOURNAL
- Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice
- (2012) M. A. Pouladi et al. HUMAN MOLECULAR GENETICS
- Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease
- (2012) A. Valencia et al. HUMAN MOLECULAR GENETICS
- A fully humanized transgenic mouse model of Huntington disease
- (2012) Amber L. Southwell et al. HUMAN MOLECULAR GENETICS
- Mutant huntingtin impairs immune cell migration in Huntington disease
- (2012) Wanda Kwan et al. JOURNAL OF CLINICAL INVESTIGATION
- Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity
- (2012) Marcus Fändrich JOURNAL OF MOLECULAR BIOLOGY
- Soluble -Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology
- (2012) M. E. Larson et al. JOURNAL OF NEUROSCIENCE
- Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease
- (2012) J. Bouchard et al. JOURNAL OF NEUROSCIENCE
- A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis
- (2012) Di Xue et al. NEUROBIOLOGY OF DISEASE
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
- (2011) Mathias Jucker et al. ANNALS OF NEUROLOGY
- Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses
- (2011) Xi Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Interaction between pathogenic proteins in neurodegenerative disorders
- (2011) Kurt A. Jellinger JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Protein Conformational Pathology in Alzheimers and Other Neurodegenerative Diseases; New Targets for Therapy
- (2010) E. Zerovnik Current Alzheimer Research
- Synphilin-1 attenuates neuronal degeneration in the A53T -synuclein transgenic mouse model
- (2010) W. W. Smith et al. HUMAN MOLECULAR GENETICS
- Synergistic Interactions between A , Tau, and -Synuclein: Acceleration of Neuropathology and Cognitive Decline
- (2010) L. K. Clinton et al. JOURNAL OF NEUROSCIENCE
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
- (2010) Chiara Zuccato et al. PHYSIOLOGICAL REVIEWS
- Targeting of Embryonic Stem Cells by Peptide-Conjugated Quantum Dots
- (2010) Shuai Lu et al. PLoS One
- Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
- (2009) K. E. Paleologou et al. BRAIN
- Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers
- (2009) Xiao-ping Wang et al. FEBS LETTERS
- Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice
- (2008) M. Gray et al. JOURNAL OF NEUROSCIENCE
- DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates
- (2008) Jennifer Illuzzi et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Nigral burden of α-synuclein correlates with striatal dopamine deficit
- (2008) Gabor G. Kovacs et al. MOVEMENT DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More